BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 7545549)

  • 21. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. III. Analysis of viral glycoproteins recognized by CTL clones by using recombinant herpes simplex viruses.
    Yasukawa M; Zarling JM
    J Immunol; 1985 Apr; 134(4):2679-82. PubMed ID: 2579149
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional cytotoxic T cells are associated with focal lesions in the brains of SJL mice with experimental herpes simplex encephalitis.
    Hudson SJ; Streilein JW
    J Immunol; 1994 Jun; 152(11):5540-7. PubMed ID: 8189071
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Virus-specific cytotoxic T cell-mediated lysis of lymphocytes in vitro and in vivo.
    Kyburz D; Speiser DE; Aebischer T; Hengartner H; Zinkernagel RM
    J Immunol; 1993 Jun; 150(11):5051-8. PubMed ID: 7684417
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of the cytolytic T-lymphocyte response to herpes simplex virus type 1 glycoprotein B during primary and secondary infection.
    Nugent CT; Wolcott RM; Chervenak R; Jennings SR
    J Virol; 1994 Nov; 68(11):7644-8. PubMed ID: 7933156
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epitope mapping of full-length glycoprotein D from HSV-2 reveals a novel CD4+ CTL epitope located at the transmembrane-cytoplasmic junction.
    Cooper D; Mester JC; Guo M; Nasar F; Souza V; Dispoto S; Sidhu M; Hagen M; Eldridge JH; Natuk RJ; Pride MW
    Cell Immunol; 2006 Feb; 239(2):113-20. PubMed ID: 16762332
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intranasal immunization with CTL epitope peptides from HIV-1 or ovalbumin and the mucosal adjuvant cholera toxin induces peptide-specific CTLs and protection against tumor development in vivo.
    Porgador A; Staats HF; Faiola B; Gilboa E; Palker TJ
    J Immunol; 1997 Jan; 158(2):834-41. PubMed ID: 8993001
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Priming of measles virus-specific CTL responses after immunization with a CTL epitope linked to a fusogenic peptide.
    Partidos CD; Vohra P; Steward MW
    Virology; 1996 Jan; 215(1):107-10. PubMed ID: 8553582
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunization with a single major histocompatibility complex class I-restricted cytotoxic T-lymphocyte recognition epitope of herpes simplex virus type 2 confers protective immunity.
    Blaney JE; Nobusawa E; Brehm MA; Bonneau RH; Mylin LM; Fu TM; Kawaoka Y; Tevethia SS
    J Virol; 1998 Dec; 72(12):9567-74. PubMed ID: 9811690
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vaccination with the immediate-early protein ICP47 of herpes simplex virus-type 1 (HSV-1) induces virus-specific lymphoproliferation, but fails to protect against lethal challenge.
    Banks TA; Jenkins FJ; Kanangat S; Nair S; Dasgupta S; Foster CM; Rouse BT
    Virology; 1994 Apr; 200(1):236-45. PubMed ID: 8128625
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modified-self-induced modulation of the immune response to herpes simplex virus: effect on antibody formation, cytotoxic T lymphocyte induction, and survival.
    Wilson LA; Karabin JM; Smith JW; Dawson D; Scott DW
    J Immunol; 1984 Mar; 132(3):1522-8. PubMed ID: 6198395
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Herpes simplex virus type 1-specific cytotoxic T lymphocytes recognize immediate-early protein ICP27.
    Banks TA; Allen EM; Dasgupta S; Sandri-Goldin R; Rouse BT
    J Virol; 1991 Jun; 65(6):3185-91. PubMed ID: 1709698
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship among immunodominance of single CD8+ T cell epitopes, virus load, and kinetics of primary antiviral CTL response.
    Weidt G; Utermöhlen O; Heukeshoven J; Lehmann-Grube F; Deppert W
    J Immunol; 1998 Mar; 160(6):2923-31. PubMed ID: 9510196
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phenotypic characteristics associated with the acquisition of HSV-specific CD8 T-lymphocyte-mediated cytolytic function in vitro.
    McNally JM; Andersen HA; Chervenak R; Jennings SR
    Cell Immunol; 1999 May; 194(1):103-11. PubMed ID: 10357886
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of a lentiviral vector encoding a HCMV-chimeric IE1-pp65 protein for epitope identification in HLA-Transgenic mice and for ex vivo stimulation and expansion of CD8(+) cytotoxic T cells from human peripheral blood cells.
    Rohrlich PS; Cardinaud S; Lulè J; Montero-Julian FA; Prodhomme V; Firat H; Davignon JL; Perret E; Monseaux S; Necker A; Michelson S; Lemonnier FA; Charneau P; Davrinche C
    Hum Immunol; 2004 May; 65(5):514-22. PubMed ID: 15172452
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of human CTL-mediated lysis by fibroblasts infected with herpes simplex virus.
    Posavad CM; Newton JJ; Rosenthal KL
    J Immunol; 1993 Nov; 151(9):4865-73. PubMed ID: 8409445
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recognition by and in vitro induction of cytotoxic T lymphocytes against predicted epitopes of the immediate-early protein ICP27 of herpes simplex virus.
    Banks TA; Nair S; Rouse BT
    J Virol; 1993 Jan; 67(1):613-6. PubMed ID: 7677961
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A strategy for selective, CD4+ T cell-independent activation of virus-specific memory B cells for limiting dilution analysis.
    Li X; Vanitha DJ; Joo HM; He Y; Rouse BT; Sangster MY
    J Immunol Methods; 2006 Jun; 313(1-2):110-8. PubMed ID: 16730022
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytokine genetic adjuvant facilitates prophylactic intravascular DNA vaccine against acute and latent herpes simplex virus infection in mice.
    Cui FD; Asada H; Jin ML; Kishida T; Shin-Ya M; Nakaya T; Kita M; Ishii M; Iwai M; Okanoue T; Imanishi J; Mazda O
    Gene Ther; 2005 Jan; 12(2):160-8. PubMed ID: 15470476
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Progression of armed CTL from draining lymph node to spleen shortly after localized infection with herpes simplex virus 1.
    Coles RM; Mueller SN; Heath WR; Carbone FR; Brooks AG
    J Immunol; 2002 Jan; 168(2):834-8. PubMed ID: 11777979
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cell-mediated immune response to herpes simplex virus: type-specific lymphoproliferative responses in lymph nodes draining the site of primary infection.
    Jacobs RP; Aurelian L; Cole GA
    J Immunol; 1976 Jun; 116(6):1520-5. PubMed ID: 58037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.